Clinical Trial Update: CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM [NA]

View source ↗

Summary

Clinical trial update for CorMatrix ECM study investigating inflammatory markers after CABG with or without ECM; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CorMatrix ECM

Snippet

Sponsor: Inova Health Care Services | Conditions: Coronary Artery Disease | NA | Status: TERMINATED | Results posted: 2015-12-24